Thieme E-Books & E-Journals -
Klinische Pädiatrie, Table of Contents
Klin Padiatr 2017; 229(06): 361-366
DOI: 10.1055/s-0037-1607403
Abstracts
Georg Thieme Verlag KG Stuttgart · New York

Interference with the function of MYC – novel insights into the consequences of class I HDAC inhibition in Group 3 Medulloblastoma

Authors

  • J Ecker

    1   Clinical Cooperation Unit Pediatric Oncology, Pre-Clinical Program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany
    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany
    3   Center for Individualized Pediatric Oncology (ZIPO) and Brain Tumors, Translational program, Hopp-Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany

  • I Oehme

    1   Clinical Cooperation Unit Pediatric Oncology, Pre-Clinical Program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany
    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany

  • F Selt

    1   Clinical Cooperation Unit Pediatric Oncology, Pre-Clinical Program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany
    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany
    3   Center for Individualized Pediatric Oncology (ZIPO) and Brain Tumors, Translational program, Hopp-Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany

  • M Kool

    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany
    4   Division of Pediatric Neurooncology, Pre-Clinical program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany

  • L Chavez

    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany
    4   Division of Pediatric Neurooncology, Pre-Clinical program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany

  • J Hohloch

    1   Clinical Cooperation Unit Pediatric Oncology, Pre-Clinical Program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany
    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany

  • G Valinciute

    1   Clinical Cooperation Unit Pediatric Oncology, Pre-Clinical Program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany
    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany

  • CM van Tilburg

    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany
    3   Center for Individualized Pediatric Oncology (ZIPO) and Brain Tumors, Translational program, Hopp-Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany

  • V Thatikonda

    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany
    4   Division of Pediatric Neurooncology, Pre-Clinical program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany

  • M Schnölzer

    5   Functional Proteome Analysis (B100), German Cancer Research Center (DKFZ), Heidelberg, Germany

  • U Warnken

    5   Functional Proteome Analysis (B100), German Cancer Research Center (DKFZ), Heidelberg, Germany

  • R Wechsler-Reya

    6   Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA

  • SM Pfister

    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany
    3   Center for Individualized Pediatric Oncology (ZIPO) and Brain Tumors, Translational program, Hopp-Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany
    4   Division of Pediatric Neurooncology, Pre-Clinical program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany

  • O Witt

    1   Clinical Cooperation Unit Pediatric Oncology, Pre-Clinical Program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany
    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany
    3   Center for Individualized Pediatric Oncology (ZIPO) and Brain Tumors, Translational program, Hopp-Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany

  • T Milde

    1   Clinical Cooperation Unit Pediatric Oncology, Pre-Clinical Program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany
    2   German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany
    3   Center for Individualized Pediatric Oncology (ZIPO) and Brain Tumors, Translational program, Hopp-Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany
eRefRecommend Article